{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:09:48Z","timestamp":1789898988962,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK105434"],"award-info":[{"award-number":["R01DK105434"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/mt.2016.35","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T07:54:53Z","timestamp":1455177293000},"page":"697-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA"],"prefix":"10.1016","volume":"24","author":[{"given":"Dustin J","family":"Landau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Drake","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Perez-Pinera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiruni","family":"Amarasekara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mefferd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A","family":"Gersbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.35_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tem.2009.02.003","article-title":"Emerging therapies for glycogen storage disease type I","volume":"20","author":"Koeberl","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/mt.2016.35_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.35_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2005-12-5115","article-title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2016.35_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/mt.2008.15","article-title":"AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia","volume":"16","author":"Koeberl","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/hum.2006.17.427","article-title":"Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice","volume":"17","author":"Sarkar","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.35_bib6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ymthe.2006.01.014","article-title":"Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats","volume":"13","author":"Seppen","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/mt.2011.126","article-title":"Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector","volume":"19","author":"Luo","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.35_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mt.2008.72","article-title":"Gene delivery to the juvenile mouse liver using AAV2\/8 vectors","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2009.157","article-title":"Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia","volume":"21","author":"Weinstein","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.35_bib12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mt.2010.64","article-title":"Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy","volume":"18","author":"Yiu","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib13","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.25717","article-title":"Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1038\/mt.2016.35_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2009.04.003","article-title":"Activation of glycolysis and apoptosis in glycogen storage disease type Ia","volume":"97","author":"Sun","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2016.35_bib15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.mt.6300188","article-title":"Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia","volume":"15","author":"Koeberl","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.35_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1109\/TUFFC.2013.2540","article-title":"Enhanced gene expression of systemically administered plasmid DNA in the liver with therapeutic ultrasound and microbubbles","volume":"60","author":"Raju","year":"2013","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control"},{"key":"10.1038\/mt.2016.35_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/hum.2011.106","article-title":"Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type Ia","volume":"23","author":"Demaster","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.35_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cbpa.2012.06.007","article-title":"Advances in targeted genome editing","volume":"16","author":"Perez-Pinera","year":"2012","journal-title":"Curr Opin Chem Biol"},{"key":"10.1038\/mt.2016.35_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2016.35_bib20","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","article-title":"Robust ZFN-mediated genome editing in adult hemophilic mice","volume":"122","author":"Anguela","year":"2013","journal-title":"Blood"},{"key":"10.1038\/mt.2016.35_bib21","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/nar\/gkr1214","article-title":"Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases","volume":"40","author":"Perez-Pinera","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2016.35_bib22","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.35_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","article-title":"A rapid and general assay for monitoring endogenous gene modification","volume":"649","author":"Guschin","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2016.35_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"10.1038\/mt.2016.35_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2016.35_bib26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med"},{"key":"10.1038\/mt.2016.35_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases","volume":"27","author":"Hockemeyer","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2016.35_bib28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1101\/gr.106773.110","article-title":"Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome","volume":"20","author":"DeKelver","year":"2010","journal-title":"Genome Res"},{"key":"10.1038\/mt.2016.35_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jgm.2745","article-title":"Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells","volume":"15","author":"Tay","year":"2013","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2016.35_bib30","series-title":"The American Society of Gene and Cell Therapy, vol. 21","first-page":"S188","article-title":"Vivo ZFN Mediated Targeting of Albumin as a Platform for Expression of Multiple Therapeutic Genes","author":"Sharma","year":"2013"},{"key":"10.1038\/mt.2016.35_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-006-0311-2","article-title":"Principles of therapeutic liver repopulation","volume":"29","author":"Grompe","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2016.35_bib32","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.1069193","article-title":"A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome","volume":"296","author":"Mural","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.2016.35_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.35_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1038\/mt.2016.35_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/gt.2012.67","article-title":"Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes","volume":"20","author":"Dane","year":"2013","journal-title":"Gene Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616309935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616309935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:50:05Z","timestamp":1761501005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616309935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1525001616309935"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.35","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2016.35","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}